Glucose metabolism pathway modulation

"Glucose metabolism pathway modulation" is not a specific molecular target but rather refers to the broad therapeutic strategy of altering the activity or flux through the cellular pathways that metabolize glucose. These pathways include glycolysis, gluconeogenesis, glycogen synthesis and breakdown, the pentose phosphate pathway, and oxidative phosphorylation. In oncology and other fields, modulating these pathways can impact cell growth and survival—especially in diseases like cancer where cells often exhibit altered glucose uptake and utilization ("Warburg effect")[1][4][5]. Therapeutic approaches may involve inhibiting key enzymes (such as hexokinase II [HK2], pyruvate kinase M2 [PKM2], lactate dehydrogenase [LDH]), blocking glucose transporters (GLUTs), or affecting regulatory signaling molecules[1][4][5]. However, "glucose metabolism pathway modulation" itself is not a discrete protein or gene product; it encompasses multiple potential targets within interconnected metabolic networks. Note: Because "glucose metabolism pathway modulation" is not a single molecule/receptor but an entire process involving many proteins/enzymes/transporters/regulators (e.g., GLUT1/SLC2A1 for transport; HK2 for phosphorylation; PKM2 for glycolysis), there are no unique interacting drugs/mechanisms/biomarkers/safety concerns specific to this term alone. Instead: | Category | Example Targets Within Pathway | Example Drugs | |-----------------------|----------------------------------------------|--------------------------------------| | Enzyme inhibitors | Hexokinase II (HK2), Pyruvate kinase M2 | 3-bromopyruvate, lonidamine | | Transporter inhibitors| GLUT1 | WZB117, STF‑31 | | Regulatory molecules | PI3K/Akt/mTOR signaling | Metformin | Each drug acts on one component of the broader network described by "glucose metabolism pathway modulation"[1][4][6]. Summary: *Glucose metabolism pathway modulation* describes an approach rather than a singular target. For structured data extraction purposes—such as canonical name or abbreviation—a more precise molecular entity should be specified (e.g., “Hexokinase II” instead of “glucose metabolism”).

Other names

Modulation of glucose metabolismGlucose metabolic pathway targetingTargeting glucose metabolism